Related Experiment Video
Updated: Aug 8, 2026
In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human
Insights
Stimulating natural killer (NK) cells via the CD2 pathway induces lymphokine-activated killer (LAK) effectors and tumor necrosis factor-alpha (TNF-alpha) secretion. Unlike IL-2, this CD2-induced LAK activity is not inhibited by IL-4, suggesting distinct activation pathways.
Area of Science:
- Immunology
- Cellular Biology
Background:
- Natural killer (NK) cells differentiate into lymphokine-activated killer (LAK) effectors upon interleukin-2 (IL-2) stimulation.
- Interleukin-4 (IL-4) typically inhibits this IL-2-induced LAK generation.
Purpose of the Study:
- To investigate the effect of CD2 pathway stimulation on NK cell activation and LAK effector generation.
- To determine whether IL-4 regulates CD2-induced LAK activity.
Main Methods:
- Stimulation of NK cells using anti-CD2 monoclonal antibodies.
- Measurement of tumor necrosis factor-alpha (TNF-alpha) secretion.
- Assessment of LAK effector function and NK cell proliferation.
- Comparison with IL-2 and anti-CD16 (Fc gamma RIII) stimulation.
Main Results:
- Anti-CD2 stimulation induced NK cells to secrete TNF-alpha and differentiate into LAK effectors.
- CD2-induced LAK activity was not inhibited by IL-4; instead, IL-4 enhanced LAK activity and proliferation.
- This enhancement involved increased TNF-alpha production.
- Anti-CD16-induced LAK activity was also not inhibited by IL-4.
Conclusions:
- The CD2 pathway provides an alternative route for NK cell activation, leading to LAK generation.
- IL-4 does not inhibit CD2-induced LAK activity and may enhance it via TNF-alpha.
- These findings highlight distinct regulatory mechanisms in NK cell activation pathways and the role of TNF-alpha.
Abstract:
Natural killer (NK) cells can be differentiated into lymphokine-activated killer (LAK) effectors following stimulation with interleukin (IL)-2. This induction can be negatively regulated by IL-4. In this study, we demonstrate that the stimulation of NK cells through the CD2 pathway with (9-1 + 9.6) monoclonal antibodies can also induce these cells to secrete tumor necrosis factor-alpha (TNF-alpha) and to differentiate into LAK effectors. More importantly, our data indicate that, in contrast to the IL-2-induced LAK generation, the anti-CD2-triggered LAK activity was not regulated by IL-4. IL-4 was found to enhance the LAK activity as well as NK cell proliferation following activation with anti-CD2 by a mechanism involving, at least in part, an increased TNF-alpha production. Using immobilized monoclonal antibodies against the Fc receptor (Fc gamma RIII or CD16) for NK stimulation, we also observed that the anti-CD16-induced LAK activity was not inhibited by IL-4. These data further point to a pivotal role of TNF-alpha as a regulatory cytokine in anti-CD2-induced LAK generation, and suggest that IL-4 could serve as a discriminatory factor between two distinct pathways involved in the activation of non-MHC-restricted cytotoxicity.
Related Concept Videos
01:40Cell-mediated Immune Responses
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:24B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...